Literature DB >> 25330860

Resveratrol attenuates the blood-brain barrier dysfunction by regulation of the MMP-9/TIMP-1 balance after cerebral ischemia reperfusion in rats.

Haidong Wei1, Shiquan Wang, Luming Zhen, Qianzi Yang, Zhixin Wu, Xiaoming Lei, Jianrui Lv, Lize Xiong, Rongliang Xue.   

Abstract

The collapse of the blood-brain barrier (BBB) is one of the fundamental pathophysiology changes during cerebral ischemia reperfusion injury. Resveratrol has been recently reported to reduce cerebral ischemic damage by regulating the matrix metalloproteinase-9 (MMP-9). But, more direct evidence for the explanation of the BBB protected by resveratrol against cerebral ischemia reperfusion is still lacking. Therefore, the present study was aimed to investigate the regulation of BBB integrity by resveratrol after cerebral ischemia reperfusion and to determine the role of the MMP-9 and its endogenous inhibitor TIMP-1 balance in this process. Cerebral ischemia was induced by middle cerebral artery occlusion in rats. The BBB function was evaluated by brain water content and the Evans blue dye extravasation; the activities of MMP-9 and TIMP-1 were detected by using gelatin zymography analysis, and cellular apoptosis was examined by TUNEL staining. We confirmed that resveratrol reduced the cerebral ischemia reperfusion damage, brain edema, and Evans blue dye extravasation. Moreover, we found that resveratrol improved the balance of MMP-9/TIMP-1 in terms of their expressions and activities. A TIMP-1 neutralizing antibody reversed those neuroprotective effects of resveratrol. In conclusion, resveratrol attenuated the cerebral ischemia by maintaining the integrity of BBB via regulation of MMP-9 and TIMP-1.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25330860     DOI: 10.1007/s12031-014-0441-1

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  37 in total

Review 1.  The blood-brain barrier in health and chronic neurodegenerative disorders.

Authors:  Berislav V Zlokovic
Journal:  Neuron       Date:  2008-01-24       Impact factor: 17.173

Review 2.  Matrix metalloproteinases (MMPs) in health and disease: an overview.

Authors:  Charles J Malemud
Journal:  Front Biosci       Date:  2006-05-01

3.  Melatonin decreases neurovascular oxidative/nitrosative damage and protects against early increases in the blood-brain barrier permeability after transient focal cerebral ischemia in mice.

Authors:  Hung-Yi Chen; Tsung-Ying Chen; Ming-Yang Lee; Shur-Tzu Chen; Yun-Shang Hsu; Yen-Liang Kuo; Guan-Liang Chang; Tian-Shung Wu; E-Jian Lee
Journal:  J Pineal Res       Date:  2006-09       Impact factor: 13.007

4.  Tissue inhibitor of matrix metalloproteinase-1 mediates erythropoietin-induced neuroprotection in hypoxia ischemia.

Authors:  Rhonda Souvenir; Nancy Fathali; Robert P Ostrowski; Tim Lekic; John H Zhang; Jiping Tang
Journal:  Neurobiol Dis       Date:  2011-06-06       Impact factor: 5.996

5.  The inhibitory effect of S-nitrosoglutathione on blood-brain barrier disruption and peroxynitrite formation in a rat model of experimental stroke.

Authors:  Mushfiquddin Khan; Tajinder S Dhammu; Harutoshi Sakakima; Anadakumar Shunmugavel; Anne G Gilg; Avtar K Singh; Inderjit Singh
Journal:  J Neurochem       Date:  2012-11       Impact factor: 5.372

6.  Protection against blood-brain barrier disruption in focal cerebral ischemia by the type IV phosphodiesterase inhibitor BBB022: a quantitative study.

Authors:  L Belayev; R Busto; M Ikeda; L L Rubin; A Kajiwara; L Morgan; M D Ginsberg
Journal:  Brain Res       Date:  1998-03-23       Impact factor: 3.252

Review 7.  Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities.

Authors:  William G Stetler-Stevenson
Journal:  Sci Signal       Date:  2008-07-08       Impact factor: 8.192

8.  Blood-brain barrier disruption is associated with increased mortality after endovascular therapy.

Authors:  Jean-Philippe Desilles; Aymeric Rouchaud; Julien Labreuche; Elena Meseguer; Jean-Pierre Laissy; Jean-Michel Serfaty; Bertrand Lapergue; Isabelle F Klein; Céline Guidoux; Lucie Cabrejo; Gaia Sirimarco; Philippa C Lavallée; Elisabeth Schouman-Claeys; Pierre Amarenco; Mikael Mazighi
Journal:  Neurology       Date:  2013-01-30       Impact factor: 9.910

9.  New insights into mechanism for the effect of resveratrol preconditioning against cerebral ischemic stroke: Possible role of matrix metalloprotease-9.

Authors:  Wenpeng Dong; Dakuan Gao; Hong Lin; Xiang Zhang; Nanlin Li; Fanfan Li
Journal:  Med Hypotheses       Date:  2007-06-29       Impact factor: 1.538

10.  Tissue inhibitor of metalloproteinase 1 inhibits excitotoxic cell death in neurons.

Authors:  Hiang Khoon Tan; Darren Heywood; G Scott Ralph; Alison Bienemann; Andrew H Baker; James B Uney
Journal:  Mol Cell Neurosci       Date:  2003-01       Impact factor: 4.314

View more
  21 in total

Review 1.  Factors controlling permeability of the blood-brain barrier.

Authors:  Mohammed M A Almutairi; Chen Gong; Yuexian G Xu; Yanzhong Chang; Honglian Shi
Journal:  Cell Mol Life Sci       Date:  2015-09-24       Impact factor: 9.261

Review 2.  Targeting extracellular matrix remodeling in disease: Could resveratrol be a potential candidate?

Authors:  Renu Agarwal; Puneet Agarwal
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-23

3.  Pterostilbene impact on retinal endothelial cells under high glucose environment.

Authors:  Hongjie Shen; Hua Rong
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

Review 4.  Neurovascular Dysfunction in Diverse Communities With Health Disparities-Contributions to Dementia and Alzheimer's Disease.

Authors:  Napatsorn Saiyasit; Evan-Angelo R Butlig; Samantha D Chaney; Miranda K Traylor; Nanako A Hawley; Ryleigh B Randall; Hanna V Bobinger; Carl A Frizell; Franklin Trimm; Errol D Crook; Mike Lin; Benjamin D Hill; Joshua L Keller; Amy R Nelson
Journal:  Front Neurosci       Date:  2022-06-29       Impact factor: 5.152

5.  Icariside II attenuates cerebral ischemia/reperfusion-induced blood-brain barrier dysfunction in rats via regulating the balance of MMP9/TIMP1.

Authors:  Mu-Bo Liu; Wei Wang; Jian-Mei Gao; Fei Li; Jing-Shan Shi; Qi-Hai Gong
Journal:  Acta Pharmacol Sin       Date:  2020-06-02       Impact factor: 6.150

Review 6.  Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease.

Authors:  Amy R Nelson; Melanie D Sweeney; Abhay P Sagare; Berislav V Zlokovic
Journal:  Biochim Biophys Acta       Date:  2015-12-17

Review 7.  Neuroprotective Phytochemicals in Experimental Ischemic Stroke: Mechanisms and Potential Clinical Applications.

Authors:  Hui Xu; Emily Wang; Feng Chen; Jianbo Xiao; Mingfu Wang
Journal:  Oxid Med Cell Longev       Date:  2021-04-28       Impact factor: 6.543

8.  Combination of endothelial progenitor cells and BB-94 significantly alleviates brain damage in a mouse model of diabetic ischemic stroke.

Authors:  Daixuan Zhou; Zhi Huang; Xiaoxi Zhu; Tao Hong; Yuanli Zhao
Journal:  Exp Ther Med       Date:  2021-05-21       Impact factor: 2.447

Review 9.  Therapeutic Effects of Resveratrol on Ischemia-Reperfusion Injury in the Nervous System.

Authors:  Alireza Sarkaki; Mojtaba Rashidi; Mina Ranjbaran; Aram Asareh Zadegan Dezfuli; Zahra Shabaninejad; Ebrahim Behzad; Maryam Adelipour
Journal:  Neurochem Res       Date:  2021-08-07       Impact factor: 3.996

Review 10.  Natural Products in the Prevention of Metabolic Diseases: Lessons Learned from the 20th KAST Frontier Scientists Workshop.

Authors:  Seung J Baek; Bruce D Hammock; In-Koo Hwang; Qingxiao Li; Naima Moustaid-Moussa; Yeonhwa Park; Stephen Safe; Nanjoo Suh; Sun-Shin Yi; Darryl C Zeldin; Qixin Zhong; Jennifer Alyce Bradbury; Matthew L Edin; Joan P Graves; Hyo-Young Jung; Young-Hyun Jung; Mi-Bo Kim; Woosuk Kim; Jaehak Lee; Hong Li; Jong-Seok Moon; Ik-Dong Yoo; Yiren Yue; Ji-Young Lee; Ho-Jae Han
Journal:  Nutrients       Date:  2021-05-31       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.